SHIRBLE STORE (00312) subsidiary will be required to pay the outstanding principal of 254 million yuan and accrued interest to the bank.
Swee Lee Holdings (00312) announced that on December 16, 2024, the court confirmed in its ruling that...
SHIRBLE STORE (00312) announces that on December 16, 2024, the court confirmed in its ruling that the first-instance judgment previously issued by the court is final and effective, as the court concluded that the appeal filed by the guarantor (an independent third party) of the borrower (Zhuhai Xiangyao Real Estate Development Co., Ltd.) has been withdrawn. The company's legal advisers in China also confirmed that the ruling and the first-instance judgment are final and effective. Therefore, the borrower will be required to pay to the bank (the plaintiff):
(a) approximately 254 million yuan of outstanding loan principal;
(b) approximately 1.5 million yuan of overdue interest on the loan;
(c) interest and compound interest on the outstanding loan calculated from November 2, 2023 to the payment date, subject to a maximum annual interest rate of 24% as prescribed by the court.
The borrower is a limited company established in China, and its obligations under the loan are secured by a property it owns. If the bank does not receive repayment from the borrower, the bank may auction and dispose of the property to obtain the settlement amount. The bank may also require the guarantor of the borrower to jointly and severally bear the payment under the judgment (up to a maximum debt amount of 360 million yuan).
The directors believe that enforcing the judgment will not have a significant impact on the group's department store business.
Related Articles

New stock news | Siasun Robot&Automation applies to the Hong Kong Stock Exchange again, as the leading provider of industrial intelligent mobile solutions in China for Siasun Robot&Automation.

New stock news | Wanheng Energy submits application to Hong Kong Stock Exchange

SKB BIO-B (06990): The application for clinical trial of ITGB6 ADC SKB105 new drug has been approved by the National Medical Products Administration.
New stock news | Siasun Robot&Automation applies to the Hong Kong Stock Exchange again, as the leading provider of industrial intelligent mobile solutions in China for Siasun Robot&Automation.

New stock news | Wanheng Energy submits application to Hong Kong Stock Exchange

SKB BIO-B (06990): The application for clinical trial of ITGB6 ADC SKB105 new drug has been approved by the National Medical Products Administration.






